摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Amino-2,3-bis-(2)pyridyl-chinoxalin | 7756-06-1

中文名称
——
中文别名
——
英文名称
5-Amino-2,3-bis-(2)pyridyl-chinoxalin
英文别名
2,3-di-pyridin-2-yl-quinoxalin-5-ylamine;2,3-Dipyridin-2-ylquinoxalin-5-amine
5-Amino-2,3-bis-(2)pyridyl-chinoxalin化学式
CAS
7756-06-1
化学式
C18H13N5
mdl
——
分子量
299.335
InChiKey
CAZRTPRCRLNFKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    77.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-Amino-2,3-bis-(2)pyridyl-chinoxalin 生成 9-methyl-2,3-dipyridin-2-ylpyrido[2,3-f]quinoxaline
    参考文献:
    名称:
    HEINEMANN, ULRICH;BRANDES, WILHELM;DUTZMANN, STEFAN;HANSS. LER, GERD
    摘要:
    DOI:
  • 作为产物:
    描述:
    2,3-di-2-pyridyl-5-nitroquinoxaline硫酸 作用下, 以 溶剂黄146 为溶剂, 反应 1.0h, 生成 5-Amino-2,3-bis-(2)pyridyl-chinoxalin
    参考文献:
    名称:
    Comparison of FT Raman spectra of some 5-nitroquinoxalines and their electropolymers
    摘要:
    FT Raman spectroscopy was used to characterize a set of five newly synthesized 5-nitroquinoxaline derivatives 2,3-disubstituted with 2-pyrrolyl, 2-furyl, 2-thienyl, phenyl and 2-pyridyl groups. Afterwards the 5-nitroquinoxalines were electrochemically reduced to 5-aminoquinoxalines and electropolymerized as films on the Pt electrode coated with porous Au. Comparing the SERS spectra of polymers with the Raman spectra of monomers, a mechanism of polymerization has been suggested. Specific spectral and electrochemical properties of films based on pyrrole substituted 5-aminoquinoxaline were verified by electropolymeriration of 2,3-dipyrrol-2 ' -yl-5-nitroquinoxaline without a reduction step. (C) 2001 Elsevier Science B.V. All rights reserved.
    DOI:
    10.1016/s0022-2860(01)00453-7
点击查看最新优质反应信息

文献信息

  • Vasculostatic agents and methods of use thereof
    申请人:Wrasidlo Wolfgang
    公开号:US20070208019A1
    公开(公告)日:2007-09-06
    Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example, stroke, myocardial infarction, cancer, ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases, inflammatory diseases, vascular leakage syndrome, edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.
    本发明提供了用于治疗与血管稳态受损有关的疾病的方法和组合物。本发明的方法和组合物可用于治疗各种疾病,例如中风、心肌梗死、癌症、缺血/再灌注损伤、自身免疫疾病,如类风湿性关节炎、眼部疾病,如视网膜病变或黄斑退化或其他玻璃体视网膜疾病、炎症性疾病、血管渗漏综合征、水肿、移植排斥、成人/急性呼吸窘迫综合征(ARDS)等等。
  • VASCULOSTATIC AGENTS AND METHODS OF USE THEREOF
    申请人:Wrasidlo Wolfgang
    公开号:US20100278811A1
    公开(公告)日:2010-11-04
    Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example, stroke, myocardial infarction, cancer, ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases, inflammatory diseases, vascular leakage syndrome, edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.
    本发明提供了用于治疗与血管稳态受损相关的疾病的组合物和方法。本发明的方法和组合物可用于治疗各种疾病,例如中风、心肌梗塞、癌症、缺血/再灌注损伤、自身免疫疾病,如类风湿性关节炎、眼部疾病,如视网膜病变或黄斑变性或其他玻璃体视网膜疾病、炎症性疾病、血管渗漏综合症、水肿、移植排斥、成人/急性呼吸窘迫综合症(ARDS)等。
  • Vasculostatic Agents and Methods of Use Thereof
    申请人:Wrasidlo Wolfgang
    公开号:US20100330030A1
    公开(公告)日:2010-12-30
    Compositions and methods and are provided for treating disorders associated with compromised vasculostasis. Invention methods and compositions are useful for treating a variety of disorders including for example, stroke, myocardial infarction, cancer, ischemia/reperfusion injury, autoimmune diseases such as rheumatoid arthritis, eye diseases such as retinopathies or macular degeneration or other vitreoretinal diseases, inflammatory diseases, vascular leakage syndrome, edema, transplant rejection, adult/acute respiratory distress syndrome (ARDS), and the like.
    提供用于治疗与血管稳定性受损相关的疾病的组合物和方法。发明的方法和组合物可用于治疗多种疾病,包括中风、心肌梗塞、癌症、缺血/再灌注损伤、自身免疫疾病如类风湿性关节炎、眼部疾病如视网膜病变或黄斑变性或其他玻璃体视网膜疾病、炎症性疾病、血管渗漏综合征、水肿、移植排斥、成人/急性呼吸窘迫综合征(ARDS)等。
  • HEINEMANN, ULRICH;BRANDES, WILHELM;DUTZMANN, STEFAN;HANSS. LER, GERD
    作者:HEINEMANN, ULRICH、BRANDES, WILHELM、DUTZMANN, STEFAN、HANSS. LER, GERD
    DOI:——
    日期:——
  • US7208493B2
    申请人:——
    公开号:US7208493B2
    公开(公告)日:2007-04-24
查看更多